After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...

With shortages of its blockbuster obesity now declared resolved in the USA, Denmark’s Novo Nordisk (NOV: N) is moving to make ...

Privately-held Cambridge, USA-based biotech Gensaic announced a potentially lucrative license and discovery collaboration ...

New York, USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Novo Nordisk’s OZEMPIC Approval Heat Up the Chronic Kidney Disease Therapeutic Market | DelveInsight The FDA’s recent approval of OZEMPIC ...

Compounded GLP-1s have become more widespread, but are they safe? Some argue that compounding is nothing new, while others believe these drugs are dangerous for patients.

While the TV spot did not call out Novo Nordisk and Eli Lilly by name ... Novo fired back with an ad in The New York Times and USA Today, which posed the question to potential compounding ...

The Big Pharma ran an ad in The New York Times and USA Today on Monday calling out the potential risks of compounded drugs. Novo's "Check Before You Inject" ad (Novo Nordisk) “Do you really know ...

Over 31 million Americans borrowed a collective $74 billion to pay for healthcare last year, a West Health-Gallup survey ...

During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...